Page 36 - Glucose Monitoring Devices
P. 36

References     31




                  [130] Price D, Walker T. The rationale for continuous glucose monitoring-based diabetes
                       treatment decisions and non-adjunctive continuous glucose monitoring use. European
                       Endocrinology 2016;12:24. https://doi.org/10.17925/ee.2016.12.01.24.
                  [131] Dov  c K, Bratina N, Battelino T. A new horizon for glucose monitoring. Hormone
                       Research in Paediatrics 2015;83:149e56. https://doi.org/10.1159/000368924.
                  [132] Charleer S, Mathieu C, Nobels F, De Block C, Radermecker R, Hermans M, et al.
                       Effect of continuous glucose monitoring on glycemic control, acute admissions, and
                       quality of life: a real-world study. Journal of Clinical Endocrinology and Metabolism
                       2018;103:1224e32. https://doi.org/10.1210/jc.2017-02498.
                  [133] Rodbard D. Continuous glucose monitoring: a review of recent studies demonstrating
                       improved glycemic outcomes. Diabetes Technology and Therapeutics 2017;19.
                       https://doi.org/10.1089/dia.2017.0035. S-25-S-37.
                  [134] Battelino T. Continuous glucose monitoring efficacy in routine use. Journal of Clinical
                       Endocrinology and Metabolism 2018;103:2414e6. https://doi.org/10.1210/jc.2018-
                       00275.
                  [135] Aleppo G, Laffel L, Ahmann A, Hirsch I, Kruger D, Peters A, et al. A practical
                       approach to using trend arrows on the dexcom G5 CGM system for the management
                       of adults with diabetes. Journal of the Endocrine Society 2017;1:1445e60. https://
                       doi.org/10.1210/js.2017-00388.
   31   32   33   34   35   36   37   38   39   40   41